价格

GPR35

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

GPR35 AGONIST COMPOUNDS
EP 4326708 A1申请人: HEPTARES THERAPEUTICS LTD优先权: 2021
CN
EP
US
WO
4 件公开
GPR35 MODULATORS
- US 20260216198 A1
  申请人: THIRTYFIVEBIO LTD优先权: 2023
  CN
  EP
  US
  WO
  4 件公开
- US 11053251 B2
  申请人: PROMETHEUS BIOSCIENCES INC优先权: 2019
  CN
  US
  3 件公开
- EP 4780437 A1
  申请人: PROMETHEUS BIOSCIENCES INC优先权: 2023
  EP
  WO
  2 件公开
BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS
EP 4676926 A1申请人: THIRTYFIVEBIO LTD优先权: 2023
CN
EP
WO
3 件公开
(HETERO)ARYL-SULFONAMIDE COMPOUNDS AS MODULATORS OF GPR35
EP 4727652 A1申请人: THIRTYFIVEBIO LTD优先权: 2023
CN
EP
WO
3 件公开
Method of using GPR35 to identify metabolic-stabilizing compounds
US 8039219 B2申请人: ARENA PHARM INC优先权: 2006
US
3 件公开
Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
US 9040583 B2申请人: ABOOD MARY E优先权: 2010
US
3 件公开
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX
US 2012022116 A1申请人: DENG HUAYUN优先权: 2011
CN
US
2 件公开
3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION
WO 2020114290 A1申请人: TAIZHOU GUOKEHUAWU BIOMEDICAL TECH CO LTD优先权: 2018
CN
WO
2 件公开
THERAPEUTIC AGENTS TARGETING GPR35
US 2023151017 A1申请人: PROMETHEUS BIOSCIENCES INC优先权: 2020
US
WO
2 件公开
GPR35 MODULATORS AND USES THEREOF
US 20250214976 A1申请人: CROSSIGNAL THERAPEUTICS INC优先权: 2022
CN
US
2 件公开

药物

GPR35

专利

GPR35 MODULATORS